Innoviva (INVA) EBT Growth (3y) (2013 - 2026)
Innoviva (INVA) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 40.43% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 78.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.65% |
| Dec 31, 2025 | -2.43% |
| Sep 30, 2025 | -27.89% |
| Jun 30, 2025 | 52.44% |
| Mar 31, 2025 | -41.99% |
| Dec 31, 2024 | 29.78% |
| Sep 30, 2024 | -68.04% |
| Jun 30, 2024 | -31.78% |
| Mar 31, 2024 | -29.62% |
| Dec 31, 2023 | -57.91% |
| Sep 30, 2023 | 38.07% |
| Jun 30, 2023 | -63.37% |
| Mar 31, 2023 | -24.31% |
| Dec 31, 2022 | -30.58% |
| Sep 30, 2022 | 82.75% |
| Jun 30, 2022 | -28.68% |
| Mar 31, 2022 | -2.69% |
| Dec 31, 2021 | -37.75% |
| Sep 30, 2021 | 97.89% |
| Jun 30, 2021 | 33.99% |